BGM Group Ltd. (BGM)

↓ Download CSV

CIK 0001779578 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated E9
  • Fiscal year ends Sep 30

In fiscal 2025, BGM Group Ltd. reported revenue of $37.92M, up 51.1% from the prior year. The company ran a net loss, with a net margin of -52.6% and a gross margin of 16.6%. It held $433.81M in total assets against $41.92M in total liabilities.

Key ratios (FY2025)

16.6%
Gross margin
-33.2%
Operating margin
-52.6%
Net margin
-5.1%
Return on equity
+51.1%
Revenue growth (YoY)
Metric (FY)202520242023202220212020201920182017
Revenue$37.92M$25.10M$46.47M$64.86M$57.10M$50.03M$46.10M$50.37M
Cost of Revenue$31.61M$20.98M$44.72M$58.63M$51.46M$42.49M$36.42M$42.24M
Gross Profit$6.31M$4.11M$1.75M$6.23M$5.64M$7.54M$9.68M$8.13M
Operating Income-$12.58M-$563.8K-$2.61M$2.10M$2.39M$4.81M$6.18M$5.97M
Net Income-$19.94M-$1.44M-$7.78M$1.08M$3.15M$5.06M$5.91M$5.20M
EPS (Diluted)$-0.18$-0.20$-1.08$0.15$0.09$0.17$0.18
Total Assets$433.81M$53.00M$51.26M$64.53M$75.35M$48.14M$35.27M
Total Liabilities$41.92M$8.91M$6.91M$9.56M$18.68M$19.30M$12.63M
Shareholders' Equity$391.90M$44.09M$44.35M$54.96M$56.67M$28.84M$22.64M$17.72M$13.66M
Cash & Equivalents$9.82M$9.82M$7.48M$14.32M$10.47M$11.87M$4.59M
Operating Cash Flow-$2.37M$544.2K$312.2K$12.65M$345.0K$5.08M-$580.2K$4.44M
Capital Expenditures$1.57M$240.1K$179.8K$2.03M$1.49M$449.8K$616.4K$1.12M
Shares Outstanding200.62M7.23M7.23M7.23M35.75M30.00M30.00M